Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

Clinical trial NCT06515678 · UNKNOWN

Trial details

NCT number: NCT06515678
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: UNKNOWN
Study type: OBSERVATIONAL

Ovarian Cancer Antiangiogenic-Associated Hypertension Adjuvant Bevacizumab Hypertension

Start date: 2024-05-20
Primary completion: 2024-08-01
Enrollment: 9464

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.